• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

根除幽门螺杆菌后发现的原发性胃肿瘤患者的异时性胃癌发生率。

Incidence of metachronous gastric cancer in patients whose primary gastric neoplasms were discovered after Helicobacter pylori eradication.

机构信息

Division of Endoscopy, Department of Cancer Screening Center, Cancer Institute Hospital, Tokyo, Japan; Jiyugaoka Gastroenterology and Endoscopy Clinic, Tokyo, Japan.

Division of Gastroenterology and Hepatology, Department of Medicine, Nihon University School of Medicine, Tokyo, Japan.

出版信息

Gastrointest Endosc. 2019 Jun;89(6):1152-1159.e1. doi: 10.1016/j.gie.2019.02.026. Epub 2019 Feb 27.

DOI:10.1016/j.gie.2019.02.026
PMID:30825537
Abstract

BACKGROUND AND AIMS

The incidence of metachronous gastric cancer (MGC) in patients whose primary gastric neoplasm is discovered after Helicobacter pylori eradication remains unclear. Here, we evaluated the long-term effect of previous H pylori eradication on development of MGC after endoscopic submucosal dissection (ESD).

METHODS

We analyzed prospectively collected data of consecutive patients with successful H pylori eradication more than 1 year before (eradicated group, 180 patients) or after (control group, 602 patients) initial curative ESD. These patients were also followed by endoscopy for over 2 years. Propensity score matching and inverse probability of treatment weighting (IPTW) were used to adjust for confounding variables during data analysis. The main outcome was the incidence of MGC after initial ESD.

RESULTS

In a propensity-matched analysis of 174 pairs, the incidence of MGC was similar in the 2 cohorts (33.9 per 1000 person-years vs 40.8 per 1000 person-years in the control group, P = .454) at a median follow-up of 4.1 years (interquartile range, 3.0-5.6). Incidences were also similar in the 2 groups when data were analyzed using IPTW, even after exclusion of 123 patients with successful H pylori eradication <5 years before initial ESD. Multiple Cox regression analysis revealed age, differentiated-type histology, and initial multiplicity were predictors of MGC in patients after initial curative ESD.

CONCLUSIONS

The frequency of follow-up surveillance after initial curative ESD should be kept constant, irrespective of whether H pylori eradication is performed before or after initial curative ESD.

摘要

背景与目的

在幽门螺杆菌(H. pylori)根除后发现原发性胃肿瘤的患者中,同时性胃癌(MGC)的发生率尚不清楚。在此,我们评估了先前 H. pylori 根除对内镜黏膜下剥离(ESD)后 MGC 发生的长期影响。

方法

我们分析了前瞻性收集的连续患者数据,这些患者在初始根治性 ESD 前(根除组,180 例)或后(对照组,602 例)成功进行 H. pylori 根除超过 1 年,且这些患者还接受了超过 2 年的内镜随访。在数据分析中使用倾向评分匹配和逆概率治疗加权(IPTW)来调整混杂变量。主要结局是初始 ESD 后 MGC 的发生率。

结果

在 174 对的倾向评分匹配分析中,两组的 MGC 发生率相似(对照组为每 1000 人年 33.9 例,对照组为每 1000 人年 40.8 例,P=0.454),中位随访时间为 4.1 年(四分位距,3.0-5.6)。即使在排除了 123 例初次 ESD 前 H. pylori 根除成功<5 年的患者后,使用 IPTW 分析数据时,两组的发生率也相似。多 Cox 回归分析显示,年龄、分化型组织学和初始多发性是初始根治性 ESD 后患者发生 MGC 的预测因素。

结论

无论在初始根治性 ESD 前是否进行 H. pylori 根除,初始根治性 ESD 后随访监测的频率都应保持不变。

相似文献

1
Incidence of metachronous gastric cancer in patients whose primary gastric neoplasms were discovered after Helicobacter pylori eradication.根除幽门螺杆菌后发现的原发性胃肿瘤患者的异时性胃癌发生率。
Gastrointest Endosc. 2019 Jun;89(6):1152-1159.e1. doi: 10.1016/j.gie.2019.02.026. Epub 2019 Feb 27.
2
Incidence of and risk factors for metachronous gastric cancer after endoscopic resection and successful Helicobacter pylori eradication: results of a large-scale, multicenter cohort study in Japan.内镜切除及幽门螺杆菌成功根除术后异时性胃癌的发病率及危险因素:日本一项大规模多中心队列研究的结果
Gastric Cancer. 2016 Jul;19(3):911-8. doi: 10.1007/s10120-015-0544-6. Epub 2015 Sep 29.
3
Long-term effect of Helicobacter pylori eradication on the development of metachronous gastric cancer after endoscopic resection of early gastric cancer.早期胃癌内镜切除后,幽门螺杆菌根除对异时性胃癌发展的长期影响。
Gastrointest Endosc. 2012 Jan;75(1):39-46. doi: 10.1016/j.gie.2011.08.030. Epub 2011 Oct 21.
4
Successful Eradication of Helicobacter pylori Could Prevent Metachronous Gastric Cancer: A Propensity Matching Analysis.成功根除幽门螺杆菌可预防胃的癌前病变:一项倾向评分匹配分析。
Digestion. 2021;102(2):236-245. doi: 10.1159/000504132. Epub 2019 Nov 1.
5
Association between status and metachronous gastric cancer after endoscopic resection.内镜切除术后状态与异时性胃癌之间的关联。
World J Gastroenterol. 2016 Nov 28;22(44):9794-9802. doi: 10.3748/wjg.v22.i44.9794.
6
Effect of Helicobacter pylori eradication on metachronous recurrence after endoscopic resection of gastric neoplasm.幽门螺杆菌根除对胃肿瘤内镜切除后异时性复发的影响。
Am J Gastroenterol. 2014 Jan;109(1):60-7. doi: 10.1038/ajg.2013.404. Epub 2013 Dec 17.
7
Gastric Cancer with Submucosal Invasion after Successful Helicobacter pylori Eradication: A Propensity Score-Matched Analysis of Patients with Annual Patient Endoscopic Survey.成功根除幽门螺杆菌后发生的黏膜下浸润性胃癌:接受年度患者内镜检查患者的倾向评分匹配分析。
Digestion. 2019;99(1):59-65. doi: 10.1159/000494414. Epub 2018 Dec 14.
8
Effects of Helicobacter pylori eradication for metachronous gastric cancer prevention: a randomized controlled trial.根除幽门螺杆菌预防胃癌的作用:一项随机对照试验。
Gastrointest Endosc. 2018 Sep;88(3):475-485.e2. doi: 10.1016/j.gie.2018.05.009. Epub 2018 May 22.
9
Novel risk stratification for metachronous recurrence after curative endoscopic submucosal dissection for early gastric cancer.早期胃癌内镜黏膜下剥离术后异时性复发的新风险分层。
Gastrointest Endosc. 2018 Feb;87(2):419-428.e3. doi: 10.1016/j.gie.2017.07.005. Epub 2017 Jul 14.
10
Characteristics of Primary and Metachronous Gastric Cancers Discovered after Eradication: A Multicenter Propensity Score-Matched Study.根治术后新发原发性和异时性胃癌的临床特征:一项多中心倾向评分匹配研究。
Gut Liver. 2017 Sep 15;11(5):628-634. doi: 10.5009/gnl16357.

引用本文的文献

1
Gastric cancer risk after Helicobacter pylori eradication in gastritis and peptic ulcer: a retrospective cohort study in Japan.胃炎和消化性溃疡患者根除幽门螺杆菌后的胃癌风险:日本的一项回顾性队列研究
BMC Gastroenterol. 2025 Jul 1;25(1):463. doi: 10.1186/s12876-025-04034-3.
2
Established nomogram based on clinicopathological characteristics, lifestyle, and comorbidities risk factors for metachronous recurrence in curative endoscopic submucosal dissection.基于临床病理特征、生活方式和合并症的已建立的列线图,用于治愈性内镜黏膜下剥离术后异时性复发的风险评估。
Therap Adv Gastroenterol. 2025 Apr 14;18:17562848251330973. doi: 10.1177/17562848251330973. eCollection 2025.
3
Comorbidities related to metachronous recurrence for early gastric cancer in elderly patients.
老年早期胃癌异时性复发相关的合并症
World J Gastrointest Endosc. 2025 Mar 16;17(3):99540. doi: 10.4253/wjge.v17.i3.99540.
4
Characteristics of gastric cancers developed more than 10 years after eradication of Helicobacter pylori.根除幽门螺杆菌 10 年后发生的胃癌的特征。
Medicine (Baltimore). 2024 Nov 15;103(46):e40492. doi: 10.1097/MD.0000000000040492.
5
eradication following endoscopic resection might prevent metachronous gastric cancer: a systematic review and meta-analysis of studies from Japan and Korea.内镜切除术后根除治疗可能预防异时性胃癌:一项对日本和韩国研究的系统评价与荟萃分析
Front Med (Lausanne). 2024 Sep 2;11:1393498. doi: 10.3389/fmed.2024.1393498. eCollection 2024.
6
Predictive biomarkers for metachronous gastric cancer development after endoscopic resection of early gastric cancer.早期胃癌内镜切除术后异时性胃癌发展的预测生物标志物。
Cancer Med. 2024 Aug;13(16):e70104. doi: 10.1002/cam4.70104.
7
Optimal Surveillance of Metachronous Gastric Lesion after Endoscopic Resection of Early Gastric Cancer.早期胃癌内镜切除术后胃黏膜病变的最佳监测。
Gut Liver. 2024 Sep 15;18(5):781-788. doi: 10.5009/gnl240027. Epub 2024 Aug 8.
8
Metachronous gastric neoplasm beyond 5 years after endoscopic resection for early gastric cancer.内镜切除早期胃癌 5 年后的胃多原发肿瘤。
Surg Endosc. 2023 May;37(5):3901-3910. doi: 10.1007/s00464-023-09889-9. Epub 2023 Feb 2.
9
Kyoto classification of gastritis: Advances and future perspectives in endoscopic diagnosis of gastritis.京都胃炎分类:胃炎内镜诊断的进展与未来展望。
World J Gastroenterol. 2022 Nov 21;28(43):6078-6089. doi: 10.3748/wjg.v28.i43.6078.
10
Statistical proof of eradication in preventing metachronous gastric cancer after endoscopic resection in an East Asian population.东亚人群内镜切除术后预防异时性胃癌中根除治疗的统计学证据。
World J Gastrointest Surg. 2022 Aug 27;14(8):867-873. doi: 10.4240/wjgs.v14.i8.867.